Register Login

Thrombophilia

Webinar: Rare Thrombotic Response to a SARS-CoV-2 Vaccine

Please join us for a compelling discussion about the rare, unusual thrombotic events that develop in association with thrombocytopenia approximately one to two weeks after vaccination with a SARS-CoV-2 vaccine. This incidence of thrombocytopenia is mediated by platelet-activating antibodies against platelet-factor 4, without any exposure to heparin, and it mimics heparin-induced thrombocytopenia. Don’t miss this […]
read more

VITT Mechanism Nature Preview

Here is a research article that was rushed to print in the July 7, 2021 Nature that describes the precise pathophysiology of vaccine-induced immune thrombotic thrombocytopenia [VITT]. VITT is the critical 1/60,000 incidence adverse event associated with the adenoviral vector employed in the Astra-Zeneca and Johnson and Johnson vaccines, among others. VITT resembles heparin-induced thrombocytopenia […]
read more